Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
about
sameAs
Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in IndiaThe impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn's disease: A 5-year prospective cohort studyCD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importanceAdhesion molecules in inflammatory bowel diseaseNeutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel diseaseA simple method for assessing intestinal inflammation in Crohn's diseaseSpecific antibody response to oligomannosidic epitopes in Crohn's diseaseAntidepressants and inflammatory bowel disease: a systematic reviewA proof of concept study establishing Necator americanus in Crohn's patients and reservoir donorsA dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseAutoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relativesTrichuris suis therapy in Crohn's diseaseInfluence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort studyElevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgeryEffects of chronic inflammatory bowel diseases on left ventricular structure and function: a study protocol.Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarraysOral pathology in inflammatory bowel diseaseCurrent tecniques and new perpectives research of magnetic resonance enterography in pediatric Crohn's diseasePharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsIntegrin-based therapeutics: biological basis, clinical use and new drugsIntestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient managementMRI for Crohn's Disease: Present and FutureA computer-assisted model for detection of MRI signs of Crohn's disease activity: future or fiction?National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group ReportEvidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in JapanAdalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trialEvaluation of inflammatory activity in Crohn's disease and ulcerative colitisAssociation between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-AnalysisDesigning biologic selectivity for inflammatory bowel disease--role of vedolizumabInfluence of treatment on morphological features of mucosal inflammationSystematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel diseaseSwitch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's diseaseOlsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre studyLow serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's diseaseIncreased expression of interleukin 17 in inflammatory bowel diseaseMycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse ModelCDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial.
P2860
Q21261889-AC60054C-403A-48C3-91BB-004B6140859EQ22241776-997A89D8-247C-4D52-A344-5757C9020705Q24515348-A35D8FAE-1101-4D3A-B519-EE704110E59FQ24540422-B5C74DBC-CCE0-442A-95C8-371435D4A614Q24541344-B771EB40-AC7D-49EC-A5AB-1F4B531AC68EQ24669692-2E0C97CF-BC26-4D25-8268-FC9B55A3F797Q24669833-A4538BBB-A661-4171-9C66-6DD91D080D32Q24669936-56357EA6-1918-47BA-8CED-65DA80449BB2Q24676951-05752BBC-C276-47CC-9BC6-B8D72C39A340Q24680047-222E91E6-D05B-4EBA-9467-94DF651A2CCFQ24680126-7166D603-696B-4A4F-ABF5-FE7A5C430D9BQ24681948-29C8CC84-681C-429C-BD82-38482E1C8977Q24685735-CE389FFE-0F4B-4D09-9DD8-7B8AFA727AF0Q24685821-F31127E6-93FD-4C26-BF0F-CCBA1A127D3BQ24798856-679622E1-8525-4001-AD76-0AE901AF9283Q24804514-EE79BBB5-77C0-4BC6-84A6-A9CC32B8C625Q24814806-25FA3E54-EA3D-4E52-8398-B61888CAFE17Q26739055-97D4E08B-8FF0-4AAC-8E71-7971C51F13C7Q26739755-4590F27C-9387-4270-9D5C-29F2C1B208C8Q26768280-FD98E0BF-88A2-4F41-9762-84386DEFB6C7Q26773026-3FD9CA9B-49F0-4FEB-B1D7-AC9751336C75Q26775240-DAA4D565-1FD0-4C9E-A8B8-19D2AB127DABQ26777627-C82296F7-65D1-488E-BCA6-6A54A4384FDDQ26785603-6C912F20-EE4A-4A00-ACCA-868E673C0A96Q26822687-E2A78AF5-8ACE-41AC-A9C7-A6AA000CB22EQ26827651-C561D41E-00C2-48EB-9FA1-148C5C872A0DQ26829392-904FA9BC-B55A-4B84-9F72-D6D3534C612DQ26829488-376620A7-41B4-4A0D-9C08-9CC9A70F96A0Q26996550-95FA21FA-7AA3-4E20-86BB-0F2687C28EBDQ28082169-DD5FA704-60E1-4A6B-AA3C-C78E8583A9A0Q28083872-6C947EF5-BF78-4B9B-BF03-E0420167425CQ28192791-61663F51-5E11-4C7F-AA7A-A20AC373C81CQ28254207-A6BFE998-4F1D-45A3-AF03-E927C0CA8341Q28345937-DEBB3248-8AB3-4E22-BB8F-B766DFC44931Q28353977-966EA66F-13A4-4025-9306-484EBC96AC42Q28360089-EF388B6F-A21D-4ABE-9B85-3933C8C040C9Q28390019-3FC403F9-F60B-4372-A479-4CC0042BB861Q29622829-25C4555D-1B8C-4B3D-BD4A-A1B6D9433386Q30386671-AAADF4D1-5E7C-47B0-8807-CAF3A6FB46D4Q30444398-9AFDB55C-2C37-4922-831D-02437115ACBD
P2860
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
description
1976 nî lūn-bûn
@nan
1976 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի մարտին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Development of a Crohn's disea ...... perative Crohn's Disease Study
@ast
Development of a Crohn's disea ...... perative Crohn's Disease Study
@en
Development of a Crohn's disea ...... perative Crohn's Disease Study
@nl
type
label
Development of a Crohn's disea ...... perative Crohn's Disease Study
@ast
Development of a Crohn's disea ...... perative Crohn's Disease Study
@en
Development of a Crohn's disea ...... perative Crohn's Disease Study
@nl
prefLabel
Development of a Crohn's disea ...... perative Crohn's Disease Study
@ast
Development of a Crohn's disea ...... perative Crohn's Disease Study
@en
Development of a Crohn's disea ...... perative Crohn's Disease Study
@nl
P2093
P3181
P1433
P1476
Development of a Crohn's disea ...... perative Crohn's Disease Study
@en
P2093
P304
P3181
P407
P577
1976-03-01T00:00:00Z